AYTU icon

AYTU BioPharma
AYTU

Overview Fund Activity

44 hedge funds and large institutions have $6.03M invested in AYTU BioPharma in 2022 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 8 increasing their positions, 13 reducing their positions, and 8 closing their positions.

Holders
44
Holders Change
-2
Holders Change %
-4.35%
% of All Funds
0.7%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
8
Reduced
13
Closed
8
Calls
$177K
Puts
–
Net Calls
+$177K
Net Calls Change
-$44K

Top Buyers

1
AC
1
Armistice Capital
New York
$2.57M
2
Renaissance Technologies
2
Renaissance Technologies
New York
$827K
3
Susquehanna International Group
3
Susquehanna International Group
Pennsylvania
$62K
4
Goldman Sachs
4
Goldman Sachs
New York
$54K
5
Two Sigma Advisers
5
Two Sigma Advisers
New York
$26K

Top Sellers

1
PSC
1
Piper Sandler & Co
Minnesota
$0
2
Vanguard Group
2
Vanguard Group
Pennsylvania
$780K
3
Morgan Stanley
3
Morgan Stanley
New York
$56K
4
Citadel Advisors
4
Citadel Advisors
Florida
$0
5
OQS
5
Occudo Quantitative Strategies
Florida
$0
Name Market Value Shares Shares
Change 		Shares
Change %
GWS
51
Glassman Wealth Services
Virginia
$0 1 +1 –
Barclays
52
Barclays
United Kingdom
$0 1 +1 –
CAGAS
53
Capital Advisory Group Advisory Services
Minnesota
$0 1 +1 –
MCC
54
Money Concepts Capital
Florida
$0 50 +50 New
Northwestern Mutual Wealth Management
55
Northwestern Mutual Wealth Management
Wisconsin
$0 100 +100 New
1 2
3